Caterina Scuderi

Pubblicazioni

Titolo Pubblicato in Anno
The Impact of Complex PTSD on Suicide Risk in Patients with Bipolar Disorder: A Cross-Sectional Study JOURNAL OF CLINICAL MEDICINE 2024
Unraveling the Complexity: Exploring the Intersection of Panic Disorder, Dissociation, and Complex Post-Traumatic Stress Disorder BEHAVIORAL SCIENCES 2024
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features BRAIN BEHAVIOR AND IMMUNITY 2024
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD TRANSLATIONAL PSYCHIATRY 2024
Exploring the Interplay between Complex Post-Traumatic Stress Disorder and Obsessive–Compulsive Disorder Severity: Implications for Clinical Practice MEDICINA 2024
How effective are mood stabilizers in treating bipolar patients comorbid with cPTSD? Results from an observational study INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS 2024
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress TRANSLATIONAL PSYCHIATRY 2023
Resilient and vulnerable rats to acute foot shock stress show different glial cell responses: possible rescue of pathological alterations by a single ketamine administration BRITISH JOURNAL OF PHARMACOLOGY 2023
Co-ultramicronized palmitoylethanolamide/luteolin restores the astrocyteoligodendrocyte cross-talk required for myelination via peroxisome proliferator-activated receptor-a in an in vitro model of Alzheimer's disease BRITISH JOURNAL OF PHARMACOLOGY 2023
How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy? NEURAL REGENERATION RESEARCH 2022
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex FRONTIERS IN PHARMACOLOGY 2022
Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease BIOMEDICINES 2022
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease FRONTIERS IN AGING NEUROSCIENCE 2022
Sorafenib chemosensitization by caryophyllane sesquiterpenes in liver, biliary, and pancreatic cancer cells: the role of STAT3/ABC transporter axis PHARMACEUTICS 2022
Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic NEUROCHEMICAL RESEARCH 2022
Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications BIOMOLECULES 2022
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes BIOMOLECULES 2021
Successful and unsuccessful brain aging in pets: Pathophysiological mechanisms behind clinical signs and potential benefits from palmitoylethanolamide nutritional intervention ANIMALS 2021
Post-COVID-19 neuropsychiatric syndrome: Is maladaptive glial recovery to blame? ACTA PHYSIOLOGICA 2021
Systemic Inflammation and Astrocyte Reactivity in the Neuropsychiatric Sequelae of COVID-19: Focus on Autism Spectrum Disorders FRONTIERS IN CELLULAR NEUROSCIENCE 2021

Progetti di Ricerca

Laboratori di ricerca

Laboratorio di farmacologia dei processi neurodegenerativi (Dipartimento Fisiologia & Farmacologia – CU024)

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma